Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease

← catalyst calendar

NCT05931380 · results posted

Sponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.

Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
238actual
Sites
16
Country
Japan

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2023-07-31actualWhen the study began enrolling
Primary completion2025-06-19actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-06-19actualThe whole study's end, after follow-up
First posted2023-07-05actualWhen this record first appeared on the registry
Results posted2026-07-20actualWhen the sponsor posted results to the registry
Record updated2026-07-20actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Obesity

Interventions

  • Drug: Orforglipron
  • Drug: Placebo

Primary outcomes

what the primary-completion date above is the date OF
Percent Change From Baseline in Body Weight at Week 72
measured Baseline, Week 72
Percentage of Participants Who Achieved With Greater Than or Equal to (≥) 5% Body Weight Reduction From Baseline
measured Baseline to Week 72

Posted documents

hosted by the registry — we link, never re-serve
Study Protocol: Amendment (b)posted 2023-12-07 · 1.7 MB · Prot_000.pdf
Study Protocol: Errata to Amendment (b)posted 2024-01-11 · 179 KB · Prot_001.pdf
Statistical Analysis Planposted 2025-08-05 · 994 KB · SAP_002.pdf

Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed